The average clinical trial informed consent document is 18 pages long, written at a 15th-grade reading level, and handed to patients who are often anxious, in a hurry, and not trained in clinical research. Here's what every section means and what you should never sign away.
Informed consent is the process by which a participant voluntarily agrees to join a research study after being fully informed about what the study involves. It's governed by the Belmont Report (1979) and codified in federal regulations (45 CFR 46 — the "Common Rule").
Crucially, informed consent is a process, not a signature. Signing the form documents your consent, but the actual informed consent happens in the conversation before you sign — when the research team explains the study, answers your questions, and you decide freely.
Your core rights as a participant:
You can withdraw from a study at any time, for any reason, without penalty or loss of benefits you're entitled to. Participation is always voluntary. Declining or withdrawing cannot affect your standard medical care.
What question is this trial trying to answer? Is it testing whether a treatment works (efficacy), whether it's safe (safety/tolerability), or both? Look for the phase number: Phase 1 = primarily safety, Phase 2 = efficacy signals + safety, Phase 3 = definitive efficacy in larger population.
This section should tell you: how many visits, how long each visit takes, what procedures will be done (blood draws, imaging, biopsies), and how long you'll be in the study. Calculate the total time commitment honestly — include travel. Trials that underestimate burden are one of the main reasons participants drop out.
This is the most important section and also the most legally protective. It will list known risks from prior studies, anticipated side effects, and often a catchall about "unknown risks." Read this carefully.
Ask the research team: "What side effects have participants in earlier phases experienced?" The consent form lists possible risks; the team can tell you what's been observed in practice.
Be skeptical of vague benefits language. The honest consent form will say something like "You may not personally benefit from participation, though your participation may help researchers develop future treatments." Direct benefit to you is uncertain in most trials — what you're getting is access to a treatment that may help, plus close medical monitoring.
What are your other treatment options if you don't join this trial? This section is often thin in consent forms but is critically important. Your doctor can expand on this — what is the current standard of care, and how does trial participation compare?
Who will have access to your data? Typically: the research team, the sponsoring company (if industry-funded), the IRB (Institutional Review Board), and regulatory agencies like the FDA. Your identity is protected through coding — your samples and data are assigned a number, not your name.
Will you be paid for participation? If so, how much and when? Who covers study-related medical costs? What happens if you're injured during the study — who pays for treatment? (This is a critical question for Phase 1 trials.)
This section restates your right to withdraw at any time. Read it even if you've seen it before — some consent forms include language about data already collected that cannot be withdrawn. Know exactly what "withdrawal" means for your data.
Federal regulations require that consent documents be written in "language understandable to the subject." In practice, the average consent form is far beyond the reading level of most patients. This is especially problematic for patients whose first language isn't English, patients with lower literacy, and patients in acute health situations who are cognitively taxed.
The FDA's 2022 guidance encourages the use of plain language, visual aids, and electronic consent forms with layered complexity (summary first, detail available on request). Many research centers are moving in this direction, but most consent forms remain dense.
You have the right to take the form home and read it with family, or with a patient advocate. Never feel pressured to sign on the spot.
Photograph the consent document, and HealthBridge translates it into your language using on-device AI. No data leaves your phone. Available in 10 languages.
Learn About HealthBridge →For informational purposes only. Not legal or medical advice. If you have questions about a specific consent form, consult the study's IRB or a patient advocate.
Informed consent in a clinical trial is the process by which a participant voluntarily agrees to take part after being fully informed about the study's purpose, procedures, risks, benefits, and alternatives. It is a continuous process — not just signing a form — and participants can withdraw at any time without penalty.
A clinical trial consent form must include: the study purpose and procedures, foreseeable risks and discomforts, potential benefits, alternative treatments, confidentiality protections, compensation for injury if applicable, contact information for questions, and a statement that participation is voluntary and can be stopped at any time.
Yes. Signing a clinical trial consent form is entirely voluntary. You have the right to refuse participation or to withdraw at any time without losing any medical benefits you are entitled to. No one can pressure you to participate or penalize you for declining.
Clinical trial consent forms are often written at a high reading level. To understand them: ask the research team to explain any terms you don't understand, ask for a translated version if English is not your first language, use an app like MyClinicalTrials to translate and simplify consent form language, and take as much time as you need before signing.